Literature DB >> 27412301

Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?

Aleksandra Zofia Rutkowska, Evanthia Diamanti-Kandarakis1.   

Abstract

Advanced glycation end products (AGEs) are formed both during the endogenous and exogenous reactions and are implicated in the process of ageing, pathogenesis of diabetes, atherosclerosis, female fertility, and cancers. Food and smoking are the most important sources of exogenous AGEs in daily life. The biochemical composition of meal, cooking methods, time and temperature of food preparation may impact AGEs formation, therefore Western-type diet, rich in animal-derived products as well as in fast foods seems to be the main source of AGEs. Both, endogenous and exogenous AGEs can act intracellularly or during serum interaction with cell surface receptors called RAGE influencing variety of molecular pathways. Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of reproductive age. The aetiology of this disorder remains unclear, however the environmental and genetic factors may play an important role in its pathogenesis. Nevertheless, PCOS women have increased factors for reproductive and cardiometabolic comorbidities. AGEs can contribute to the pathogenesis of PCOS as well as its consequences. It has been shown that chronic inflammation and increased oxidative stress may be a link between the mechanisms of AGEs action and the metabolic and reproductive consequences of PCOS. This review highlights that high dietary AGEs intake promotes deteriorating biological effects in women with PCOS, whereas AGEs restriction seems to have beneficial impact on women health. Better understanding AGEs formation and biochemistry as well as AGE-mediated pathophysiological mechanisms may open new therapeutic avenues converging to the achievement of the complete treatment of PCOS and its consequences.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27412301     DOI: 10.2174/1381612822666160714094404

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  8 in total

1.  Correlation between follicular fluid levels of sRAGE and vitamin D in women with PCOS.

Authors:  Deepika Garg; Richard Grazi; Geralyn M Lambert-Messerlian; Zaher Merhi
Journal:  J Assist Reprod Genet       Date:  2017-08-19       Impact factor: 3.412

Review 2.  Targeting Scavenger Receptors in Inflammatory Disorders and Oxidative Stress.

Authors:  Govigerel Bayarsaikhan; Delger Bayarsaikhan; Jaewon Lee; Bonghee Lee
Journal:  Antioxidants (Basel)       Date:  2022-05-09

Review 3.  The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Development: the State of the Art.

Authors:  Vincenzina Bruni; Anna Capozzi; Stefano Lello
Journal:  Reprod Sci       Date:  2021-03-11       Impact factor: 3.060

Review 4.  Preconception resveratrol intake against infertility: Friend or foe?

Authors:  Asako Ochiai; Keiji Kuroda
Journal:  Reprod Med Biol       Date:  2019-10-12

5.  Knockdown of DPP4 promotes the proliferation and the activation of the CREB/aromatase pathway in ovarian granulosa cells.

Authors:  Lina Lin; Liman Wang
Journal:  Mol Med Rep       Date:  2022-01-11       Impact factor: 2.952

Review 6.  Impact of Dietary Advanced Glycation End Products on Female Reproduction: Review of Potential Mechanistic Pathways.

Authors:  Marco Mouanness; Zaher Merhi
Journal:  Nutrients       Date:  2022-02-24       Impact factor: 5.717

Review 7.  Contribution of Advanced Glycation End Products to PCOS Key Elements: A Narrative Review.

Authors:  Marco Mouanness; Henry Nava; Christelle Dagher; Zaher Merhi
Journal:  Nutrients       Date:  2022-08-30       Impact factor: 6.706

Review 8.  Advanced Glycation End Products (AGEs) May Be a Striking Link Between Modern Diet and Health.

Authors:  Vidhu Gill; Vijay Kumar; Kritanjali Singh; Ashok Kumar; Jong-Joo Kim
Journal:  Biomolecules       Date:  2019-12-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.